| 000 | 01366 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250514232402.0 | ||
| 264 | 0 | _c20051209 | |
| 008 | 200512s 0 0 eng d | ||
| 022 | _a1040-8428 | ||
| 024 | 7 |
_a10.1016/j.critrevonc.2005.04.002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _avan Spronsen, D J | |
| 245 | 0 | 0 |
_aNovel treatments for metastatic renal cell carcinoma. _h[electronic resource] |
| 260 |
_bCritical reviews in oncology/hematology _cSep 2005 |
||
| 300 |
_a177-91 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCarcinoma, Renal Cell _xepidemiology |
| 650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunotherapy _xmethods |
| 650 | 0 | 4 |
_aKidney Neoplasms _xepidemiology |
| 650 | 0 | 4 |
_aNeoplasm Metastasis _xphysiopathology |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aProtein Kinases _xmetabolism |
| 650 | 0 | 4 | _aTOR Serine-Threonine Kinases |
| 650 | 0 | 4 |
_araf Kinases _xantagonists & inhibitors |
| 700 | 1 | _aMulders, P F A | |
| 700 | 1 | _aDe Mulder, P H M | |
| 773 | 0 |
_tCritical reviews in oncology/hematology _gvol. 55 _gno. 3 _gp. 177-91 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.critrevonc.2005.04.002 _zAvailable from publisher's website |
| 999 |
_c15637512 _d15637512 |
||